Nirova BioSense Overview
- Year Founded
-
2019
- Status
-
Out of Business
- Latest Deal Type
-
Out of Business
Nirova BioSense General Information
Description
Developer of an implantable optical nanosensor intended to enable early detection of cancer and other diseases. The company offers a minimally invasive platform technology that can measure cancer biomarkers and protein levels and interface with wearable devices, enabling healthcare professionals to diagnose the disease early.
Contact Information
Website
www.nirovabio.comCorporate Office
- New York, NY
- United States
Corporate Office
- New York, NY
- United States
Nirova BioSense Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Out of Business | 29-Jun-2025 | Completed | Out of Business | |||
| 2. Accelerator/Incubator | Completed | Startup | ||||
| 1. Accelerator/Incubator | 19-Oct-2019 | Completed | Startup |
Nirova BioSense FAQs
-
When was Nirova BioSense founded?
Nirova BioSense was founded in 2019.
-
Where is Nirova BioSense headquartered?
Nirova BioSense is headquartered in New York, NY.
-
What industry is Nirova BioSense in?
Nirova BioSense’s primary industry is Diagnostic Equipment.
-
Is Nirova BioSense a private or public company?
Nirova BioSense is a Private company.
-
What is Nirova BioSense’s current revenue?
The current revenue for Nirova BioSense is .
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process